Melanie Chin

机构：BioClinica (United States), Bioanalytica (Switzerland) · ORCID：0000-0002-2771-0518

发表论文 108 篇 · 总被引 2992 次 · h-index 21

代表论文

• A randomised trial of oral prednisone for cystic fibrosis pulmonary exacerbation treatment (2024 · European Respiratory Journal · 被引 15)
• Trends in outpatient and inpatient visits for separate ambulatory-care-sensitive conditions during the first year of the COVID-19 pandemic: a province-based study (2023 · Frontiers in Public Health · 被引 5)
• Bitopertin shows efficacy in patients with erythropoietic protoporphyria: Results from the randomized, double-blind, placebo-controlled AURORA trial (2025 · Journal of the American Academy of Dermatology · 被引 4)
• Healthcare utilization trends in adults with asthma or COPD during the first year of COVID-19 pandemic in comparison to pre-pandemic: A population-based study (2025 · PLoS ONE · 被引 4)
• Safety and Efficacy of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease (2024 · Journal of the American Society of Nephrology · 被引 4)
• An open-label phase II study of bitopertin in adults and adolescents with erythropoietic protoporphyria or X-linked protoporphyria (2026 · Clinical and Experimental Dermatology · 被引 3)